Ciliopathies

Gene: SEC63

Amber List (moderate evidence)

SEC63 (SEC63 homolog, protein translocation regulator)
EnsemblGeneIds (GRCh38): ENSG00000025796
EnsemblGeneIds (GRCh37): ENSG00000025796
OMIM: 608648, Gene2Phenotype
SEC63 is in 6 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Comment when marking as ready: Agree, not a ciliopathy. Retain as Amber due to phenotypic overlap.
Created: 4 May 2020, 11:23 a.m. | Last Modified: 4 May 2020, 11:23 a.m.
Panel Version: 0.103

Crystle Lee (Victorian Clinical Genetics Services)

I don't know

SEC63 plays a role in protein translocation and quality control pathways in the endoplasmic reticulum.

PMID: 15133510; Reported 7 variants in 8 unrelated families with AD polycystic kidney disease. "Implicates noncilial pathways in polycystic disease in the liver "

PMID: 19876928: "Sec63 are not ciliary proteins; they are involved in the ER processing of proteins"
Created: 4 May 2020, 6:19 a.m. | Last Modified: 4 May 2020, 6:19 a.m.
Panel Version: 0.78

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Polycystic liver disease 2 (MIM#617004)

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Victorian Clinical Genetics Services
Phenotypes
  • Polycystic liver disease 2 (MIM#617004)
OMIM
608648
Clinvar variants
Variants in SEC63
Penetrance
None
Publications
Panels with this gene

History Filter Activity

4 May 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: sec63 has been classified as Amber List (Moderate Evidence).

4 May 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SEC63 were changed from to Polycystic liver disease 2 (MIM#617004)

4 May 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: SEC63 were set to

4 May 2020, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: SEC63 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

4 May 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: sec63 has been classified as Amber List (Moderate Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: SEC63 was added gene: SEC63 was added to Ciliopathies_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SEC63 was set to Unknown